Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation
Hand-out
Press Releases
Hope Medicine Inc.  
October 24, 2024

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

HMI-115 has demonstrated statistically significant improvement in endometriosis pain

avatar profile Olean Times Herald

Olean Times Herald


Local & Social